Chemours (CC) PT Lowered to $22 at RBC Capital

August 6, 2026 6:58 AM

RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $22.00 (from $26.00) while maintaining a Outperform rating.

No results found